Technical Writer - 706

We are Hiring!

Technical Writer - Documentation Control Center Team Member

Performance of documentation control via DCC system:

• Editing all documents which pass through DCC
• Technical translation of documents (English & Hebrew – Russian if possible)
• Working with all Medinol Departments in writing and updating documents
• Coordinating all activities related to creating and filing documents, including definition of training activities and follow up
• Ensuring quality and integrity of documents

Requirements:

• Education: Qualified translator / B.Sc. – preferred
• Experience with computerized documentation systems
• Mastery of MS Word and basic knowledge of Excel and Adobe Acrobat
• Meticulous output and the ability to work in an organized and orderly manner
• Ability to translate technical documents: English-Hebrew and Hebrew-English
• Ability to translate into Russian – an advantage
• Experience in a medical device company and familiarity with ISO and quality standards – an advantage

Why Join us?

ü Culture of Excellence: Be part of a company that values excellence, integrity, and a commitment to delivering the highest quality products to the market

ü Collaboration: Work with a diverse and talented group of professionals who share a common goal - delivering exceptional quality in every aspect of our work

ü Impactful Work: an opportunity to be a part of an innovative and lifesaving industry

CV to E-mail – [email protected] , write 706 in the subject line

About the company…

The Medinol Group is Dedicated to the Science of Cardiovascular Intervention.

The Medinol Group, established in 1992 by Dr. Judith Richter and Dr. Jacob (Kobi) Richter, has been a leader in advancing medical technology for cardiovascular intervention. As a privately-held company, Medinol conducts all aspects of its operations in-house, including mechanical and material research and development, quality control, regulatory affairs, clinical affairs, manufacturing, marketing and sales.

• With a portfolio of over 400 patents, the company has successfully delivered more than 2,000,000 stents and continues to achieve remarkable clinical outcomes with its advanced cardiovascular intervention technology. The Medinol Group strives to push the boundaries of innovation in the cardiovascular field and bring life-changing clinical benefits to millions of patients. The same scientific drive that led to the development of the groundbreaking NIR stent in 1996 remains the foundation of the Group's multidisciplinary team today.